These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1704275)

  • 1. Prostatic specific antigen.
    Shearer RJ
    Br J Urol; 1991 Jan; 67(1):1-5. PubMed ID: 1704275
    [No Abstract]   [Full Text] [Related]  

  • 2. Two new techniques for evaluating prostate cancer. The role of prostate-specific antigen and transrectal ultrasound.
    Hardeman SW; Wake RW; Soloway MS
    Postgrad Med; 1989 Aug; 86(2):197-8, 201, 204 passim. PubMed ID: 2474159
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical and immunologic diagnosis of cancer. Prostatic cancer.
    Malkin A
    Tumour Biol; 1987; 8(2-3):113-5. PubMed ID: 2452468
    [No Abstract]   [Full Text] [Related]  

  • 4. [The clinical evaluation of prostatic specific antigen in prostatic cancer].
    Hiromoto Y; Hiramori M; Higaki Y; Imammura K
    Nihon Hinyokika Gakkai Zasshi; 1988 Apr; 79(4):606-12. PubMed ID: 2465428
    [No Abstract]   [Full Text] [Related]  

  • 5. [The value of histochemical detection of prostate specific antigen].
    Hashimoto H; Yachiku S; Nishihara M; Arima S; Tokunaka S; Inada F
    Nihon Hinyokika Gakkai Zasshi; 1987 Aug; 78(8):1319-22. PubMed ID: 2449558
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
    Andriole GL; Catalona WJ; Becich M
    J Urol; 1992 Feb; 147(2):474. PubMed ID: 1370699
    [No Abstract]   [Full Text] [Related]  

  • 7. Uses and limitations of prostate-specific antigen in the laboratory diagnosis of prostate cancer.
    Wells DJ; Bennett BD; Gardner WA
    South Med J; 1988 Feb; 81(2):218-20. PubMed ID: 2448884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate specific antigen--a screening test for prostatic cancer?
    Powell CS; Fielding AM; Rosser K; Ames AC; Vaughton KC
    Br J Urol; 1989 Nov; 64(5):504-6. PubMed ID: 2482112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour markers in screening.
    Chadwick D
    Br J Surg; 1991 Jan; 78(1):121. PubMed ID: 1705460
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma.
    Rainwater LM; Morgan WR; Klee GG; Zincke H
    Mayo Clin Proc; 1990 Aug; 65(8):1118-26. PubMed ID: 1697014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
    Ercole CJ; Lange PH; Mathisen M; Chiou RK; Reddy PK; Vessella RL
    J Urol; 1987 Nov; 138(5):1181-4. PubMed ID: 2444720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen test: operating characteristics and assessment criteria in the diagnosis of prostatic cancer.
    Perimenis P; Markou SA; Barbalias G
    Urol Int; 1992; 48(2):171-4. PubMed ID: 1374976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current value of prostate specific membrane antigen].
    Ito T; Yamamoto S
    Nihon Rinsho; 2000 Jul; 58 Suppl():154-6. PubMed ID: 11022705
    [No Abstract]   [Full Text] [Related]  

  • 14. Report on Prostate Cancer Tumor Marker Workshop 1999.
    Partin AW; Murphy GP; Brawer MK
    Cancer; 2000 Feb; 88(4):955-63. PubMed ID: 10679666
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnostic and prognostic value of serum phosphatases and PSA (prostate-specific antigen) in prostatic carcinoma].
    Sohn M; Studer UE
    Schweiz Rundsch Med Prax; 1988 May; 77(20):551-5. PubMed ID: 2455317
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate-specific antigen and the bone scan.
    Nunan TO; O'Doherty M
    Nucl Med Commun; 1992 Aug; 13(8):579. PubMed ID: 1381068
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Prostate specific antigen for assessing response to ketoconazole and prednisone in patients with hormone refractory metastatic prostate cancer.
    Blackard CE
    J Urol; 1991 Dec; 146(6):1621-2. PubMed ID: 1719250
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of radioimmunoanalysis for tumor markers in the diagnosis of carcinoma of the testes and prostate].
    Kausitz J
    Bratisl Lek Listy; 1988 Oct; 89(10):715-24. PubMed ID: 2463063
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical aspects of diagnosis and monitoring of prostate cancer.
    Mahler C
    Horm Res; 1989; 32 Suppl 1():55-7; discussion 58. PubMed ID: 2482245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of tumor marker in prostatic carcinoma--clinical significance of the prostate specific antigen (PA)].
    Tsukamoto T; Kumamoto Y; Yamazaki K; Umehara T; Ohmura K; Miyao N
    Nihon Hinyokika Gakkai Zasshi; 1987 May; 78(5):844-52. PubMed ID: 2447316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.